Literature DB >> 15485486

Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease.

Ester Angulo1, Véronique Noé, Vicent Casadó, Josefa Mallol, Teresa Gomez-Isla, Carmen Lluis, Isidre Ferrer, Carlos J Ciudad, Rafael Franco.   

Abstract

Gene expression throughout the different stages of Alzheimer's disease was analysed in samples from cerebral cortex. The gene encoding the voltage-gated potassium channel Kv3.4 was already overexpressed in early stages of the disease, and in advanced stages Kv3.4 was present at high levels in neurodegenerative structures. This subunit regulates delayed-rectifier currents, which are primary determinants of spike repolarization in neurones. In unique samples from a patient with Alzheimer's disease whose amount of amyloid plaques was decreased by beta amyloid immunization, Kv3.4 was overexpressed. The channel subunit was expressed in the neuropil, in the remaining conventional plaques in the frontal cortex and in collapsed plaques in the orbitary cortex. Therefore, amyloid deposition in plaques does not seem to be responsible for the increase in Kv3.4 levels. Nevertheless, Kv3.4 up-regulation is related to amyloid pathology, given that transgenic mice with the Swedish mutation of amyloid precursor protein showed increased expression of Kv3.4. Up-regulation of voltage-gated potassium channel subunits alters potassium currents in neurones and leads to altered synaptic activity that may underlie the neurodegeneration observed in Alzheimer's disease. Thus, Kv3.4 likely represents a novel therapeutic target for the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485486     DOI: 10.1111/j.1471-4159.2004.02771.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  36 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

2.  Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice.

Authors:  Robert Wykes; Abigail Kalmbach; Marina Eliava; Jack Waters
Journal:  Neurobiol Aging       Date:  2011-06-15       Impact factor: 4.673

3.  BACE1 and presenilin/γ-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels.

Authors:  Carolyn C Sachse; Young Hye Kim; Marianne Agsten; Tobias Huth; Christian Alzheimer; Dora M Kovacs; Doo Yeon Kim
Journal:  FASEB J       Date:  2013-03-15       Impact factor: 5.191

4.  β-Secretase BACE1 Promotes Surface Expression and Function of Kv3.4 at Hippocampal Mossy Fiber Synapses.

Authors:  Stephanie Hartmann; Fang Zheng; Michele C Kyncl; Sandra Karch; Kerstin Voelkl; Benedikt Zott; Carla D'Avanzo; Selene Lomoio; Giuseppina Tesco; Doo Y Kim; Christian Alzheimer; Tobias Huth
Journal:  J Neurosci       Date:  2018-03-05       Impact factor: 6.167

Review 5.  Kv3 Channels: Enablers of Rapid Firing, Neurotransmitter Release, and Neuronal Endurance.

Authors:  Leonard K Kaczmarek; Yalan Zhang
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 6.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

7.  Prolonged Abeta treatment leads to impairment in the ability of primary cortical neurons to maintain K+ and Ca2+ homeostasis.

Authors:  Lana Shabala; Claire Howells; Adrian K West; Roger S Chung
Journal:  Mol Neurodegener       Date:  2010-08-13       Impact factor: 14.195

Review 8.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

9.  Mutations in KCND3 cause spinocerebellar ataxia type 22.

Authors:  Yi-Chung Lee; Alexandra Durr; Karen Majczenko; Yen-Hua Huang; Yu-Chao Liu; Cheng-Chang Lien; Pei-Chien Tsai; Yaeko Ichikawa; Jun Goto; Marie-Lorraine Monin; Jun Z Li; Ming-Yi Chung; Emeline Mundwiller; Vikram Shakkottai; Tze-Tze Liu; Christelle Tesson; Yi-Chun Lu; Alexis Brice; Shoji Tsuji; Margit Burmeister; Giovanni Stevanin; Bing-Wen Soong
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

10.  Effect of microgravity on gene expression in mouse brain.

Authors:  Antonio Frigeri; Dumitru A Iacobas; Sanda Iacobas; Grazia Paola Nicchia; Jean Francois Desaphy; Diana Conte Camerino; Maria Svelto; David C Spray
Journal:  Exp Brain Res       Date:  2008-08-14       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.